Programmable bio-chips to automate experiments

GET CONNECTED
digi.bio

Team

Frido Emans

COO & Co-Founder

Federico Muffatto

CEO & Co-Founder

Jelmer Cnossen

CTO & Co-Founder

Digi Bio

Company details

Digi.Bio is accelerating the development of life saving cell therapies with a lab-on-a-chip and computational platform that analyzes how cell therapies perform and evaluate their outcome down to the single cell level, delivering high content results in 24 hours and with minimal material waste.

NetherlandsPre-SeedAI & Machine LearningHard TechIndustrial BioIndustrial EquipmentHAX 10

Company News

What Holland can teach Silicon Valley: a joint response to unpredictability

February 12, 2021
Robohub

Three TU/e spin-offs among the best academic start-ups of 2020

November 27, 2020
Innovation Origins

Four TU/e startups competing to become ‘Best academic start-up in Netherlands’

October 2, 2020
Mirage News

Tech startups weekly: Netflix of bikes, online pharmacy and digital milk fraud detection

July 13, 2020
Silicon Canals

New partnership strives to tackle milk fraud with automated testing platform

July 7, 2020
dairyreporter.com

Get In Touch with Digi Bio

Please tell us a little bit about yourself and why you'd like to get connected. Digi Bio + SOSV will follow up with you via email.

Hidden
Hidden
Hidden
Hidden
Opt-in checkbox


We don’t spam. Our Privacy Policy and Terms of Use apply.
* If you are interested in investing directly into SOSV's portfolio of privately held companies, or into SOSV's funds, you need to meet the SEC’s criteria for accredited investor status. As an individual, you can qualify as an accredited investor by either (a) having more than $200,000 in annual income for each of the past two years (or $300,000 with your spouse) and a reasonable expectation of earning the same this year or (b) having a net worth of at least $1 million (not including your principal residence). Learn More